Ambrose Kristen 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Feb 26, 2025
Insider Transaction Report
Form 4
Ambrose Kristen
SVP & Chief Accounting Officer
Transactions
- Sale
Common Stock
2025-02-25$480.95/sh−884$425,160→ 9,086 total - Tax Payment
Common Stock
2025-02-24$483.28/sh−828$400,156→ 9,970 total
Footnotes (1)
- [F1]Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1, which was entered into on 08/08/2024.